Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
3.10
Nov 03 • 3:59 PM ET Dollar change+0.05 Percentage change(1.64%)
Aftermarket Close
3.10
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
143.13M
Enterprise Value
138.15M
Income
-1.82M
Sales
45.11M
Book/sh
0.39
Cash/sh
0.18
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
73
IPO
Apr 05, 1994
P/E
-
Forward P/E
150.12
PEG
-
P/S
3.17
P/B
7.93
P/C
17.27
P/FCF
183.50
EV/EBITDA
-
EV/Sales
3.06
Quick Ratio
2.09
Current Ratio
2.72
Debt/Eq
0.18
LT Debt/Eq
0.15
Option/Short
Yes / Yes
EPS (ttm)
-0.04
EPS next Y
0.02
EPS next Q
-0.02
EPS this Y
34.88%
EPS next Y
152.85%
EPS next 5Y
-
EPS past 3/5Y
33.31% -14.59%
Sales past 3/5Y
13.81% 11.21%
EPS Y/Y TTM
60.02%
Sales Y/Y TTM
22.41%
EPS Q/Q
213.33%
Sales Q/Q
18.15%
Insider Own
6.76%
Insider Trans
2.00%
Inst Own
55.69%
Inst Trans
-0.18%
ROA
-6.80%
ROE
-10.52%
ROIC
-8.75%
Gross Margin
60.67%
Oper. Margin
-3.66%
Profit Margin
-4.03%
SMA20
1.07%
SMA50
-0.91%
SMA200
-22.39%
Trades
Shs Outstand
46.15M
Shs Float
43.05M
52W High
6.61 -53.09%
52W Low
2.86 8.39%
Volatility
5.42% 4.53%
ATR (14)
0.15
RSI (14)
49.57
Beta
0.52
Rel Volume
0.45
Avg Volume
241.56K
Volume
109,082
Perf Week
-2.21%
Perf Month
2.99%
Perf Quarter
-24.94%
Perf Half Y
-24.02%
Perf YTD
-46.64%
Perf Year
-19.27%
Perf 3Y
39.01%
Perf 5Y
-4.32%
Perf 10Y
638.10%
Prev Close
3.05
Price
3.10
Change %
1.64%
Consensus
Buy
Avg. Price Target
$6.25
Implied Upside
+101.6%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Feb 14, 2025Downgrade
PPiper Sandler
Overweight → Neutral$4.50+45.2%
Jul 25, 2024Resumed
RILY logoRB. Riley Securities
Buy$4+29.0%
Sep 07, 2023Initiated
LLake Street
Buy$4+29.0%
Sep 07, 2023Initiated
RILY logoRB. Riley Securities
Buy$4.50+45.2%
Nov 10, 2022Upgrade
PPiper Sandler
Neutral → Overweight$3 → $3.50+12.9%
Nov 10, 2022Upgrade
CCanaccord Genuity
Hold → Buy$3 → $4+29.0%
Jan 26, 2021Downgrade
PPiper Sandler
Overweight → Neutral$9 → $4.50+45.2%
Jan 26, 2021Downgrade
CCanaccord Genuity
Buy → Hold$5+61.3%
Aug 10, 2020Initiated
HH.C. Wainwright
Buy$16+416.1%
Jul 16, 2020Initiated
CCanaccord Genuity
Buy$13+319.4%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KALBERMATTEN ADAM RChief Commercial OfficerSep 08 '26Buy3.1632,000101,120394,017Sep 09 04:32 PM
KALBERMATTEN ADAM RChief Commercial OfficerJul 28 '26Option Exercise0.0075,0000387,500Aug 06 04:11 PM
KALBERMATTEN ADAM ROfficerAug 03 '26Proposed Sale4.2625,483108,629Aug 03 05:18 PM
KALBERMATTEN ADAM RPresident-Chief Commercial OffJun 11 '26Buy3.9412,50049,275312,500Jun 15 04:34 PM
Schiller EricChief Technology OfficerMay 18 '26Buy3.915,00019,5625,000May 20 04:41 PM
Tharby Linda MChief Executive OfficerMay 15 '26Buy3.901,1914,645620,622May 20 04:02 PM
Tharby Linda MChief Executive OfficerMay 14 '26Option Exercise0.0013,9770626,757May 19 05:08 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Option Exercise0.005,3270310,458May 18 04:39 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Buy3.885,00019,400305,131May 18 04:35 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Option Exercise0.008,1930316,340May 18 04:33 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Buy3.865,50021,248308,147May 18 04:31 PM
Tharby Linda MOfficerMay 14 '26Proposed Sale3.957,32628,915May 14 05:01 PM
Pazdan ChristopherChief Operating OfficerMar 16 '26Option Exercise0.005,06405,064Mar 18 04:47 PM
Adams Thomas EdwardChief Financial OfficerMar 16 '26Option Exercise0.005,40405,404Mar 18 04:45 PM
Tharby Linda MChief Executive OfficerMar 16 '26Option Exercise0.0015,968015,968Mar 18 04:42 PM
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
President & CEOMr. Adam Kalbermatten
CFOMr. Thomas Adams
Chief Operating OfficerMr. Christopher Pazdan
Chief Technology OfficerMr. Eric Schiller